QuidelOrtho (QDEL) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
42.9mn → 67.8mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
steady at 6.9% of revenue (−3.5% YoY).
$0.0M returned vs $−83.0M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.
-41¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Over this window: gross 75.3% → 46.7%. Net margin -41.5% is below the sector median.
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 2,593.2 | 2,730.2 | 2,782.9 | 2,997.8 | 3,266.0 | 1,698.6 | ▼1.9% | +12.6% |
Cost of revenue | 1,446.5 | 1,456.0 | 1,496.4 | 1,500.7 | 1,329.8 | 420.3 | ▼2.7% | +36.4% |
Gross profit | 1,146.7 | 1,274.2 | 1,286.5 | 1,497.1 | 1,936.2 | 1,278.3 | ▼1.0% | −0.1% |
Research & development | 181.9 | 186.2 | 218.7 | 245.0 | 187.9 | 95.7 | ▼14.9% | +18.1% |
Selling, general & admin | 840.5 | 844.0 | 818.6 | 790.3 | 633.3 | 239.6 | ▲3.1% | +37.0% |
Total operating expenses | 1,274.1 | 2,193.4 | 3,247.4 | 1,358.0 | 1,092.5 | 372.3 | ▼32.5% | +55.8% |
Operating incomefeeds ROC rank | −127.4 | −919.2 | −1,960.9 | 139.1 | 843.7 | 906.0 | ▲53.1% | — |
Other income, net | −208.6 | −188.5 | −170.6 | −168.2 | −107.8 | −5.7 | — | — |
Pretax income | −336.0 | −1,107.7 | −2,131.5 | −29.1 | 735.9 | 900.3 | ▲48.0% | — |
Income tax | 33.2 | 24.1 | −79.5 | −19.0 | 187.2 | 196.1 | — | −40.8% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −369.2 | −1,131.8 | −2,052.0 | −10.1 | 548.7 | 704.2 | ▲44.8% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −5.44 | −16.69 | −30.54 | −0.15 | 9.56 | 16.43 | ▲45.4% | — |
Diluted shares (mn) | 68.70 | 67.80 | 67.20 | 66.80 | 57.40 | 42.90 | ▲0.9% | +12.1% |
| Margins | ||||||||
Gross margin22nd pct in Healthcare | 44.2% | 46.7% | 46.2% | 49.9% | 59.3% | 75.3% | ▲0.4pp | −28.6pp |
Operating margin | −4.9% | −33.7% | −70.5% | 4.6% | 25.8% | 53.3% | ▲36.8pp | −87.0pp |
Net margin25th pct in Healthcare | −14.2% | −41.5% | −73.7% | −0.3% | 16.8% | 41.5% | ▲32.3pp | −82.9pp |
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was QuidelOrtho's revenue last fiscal year?
QuidelOrtho reported revenue of $2,730.2M in fiscal 2025, down 1.9% from fiscal 2024.
What was QuidelOrtho's net income?
QuidelOrtho reported net income of −$1,131.8M in fiscal 2025, a net margin of −41.5%.

